Daiichi Sankyo to launch important Covid-19 trial: mRNA, Covid-19, and cancerĀ 

Daiichi Sankyo to launch important Covid-19 trial: mRNA, Covid-19, and cancer  Kanako Mita and Sawako Utsumi Modern Tokyo Times The Japanese pharmaceutical sector is slow off the mark compared with several nations where mRNA coronavirus vaccines and non-mRNA vaccines are already being used. However, the Japanese companies of AnGes, Daiichi Sankyo, KM Biologics, and Shionogi…